首页
按字顺浏览
期刊浏览
卷期浏览
Disposition of the Pharmacologically Active Compound [1-14C-Acetyl]-1-Acetyl-...
|
Disposition of the Pharmacologically Active Compound [1-14C-Acetyl]-1-Acetyl-4-Phenyl-1,2,4-Triazolidine-3,5-Dione in CF1Mice
作者:
Robert P. Shrewsbury,
Steven D. Wyrick,
Amy L. Elkins,
Robert A. Izydore,
Shang Y. Chen,
Merrill C. Miller,
Bruce S. Burnham,
Iris H. Hall,
期刊:
Drug Investigation
(ADIS Available online 1994)
卷期:
Volume 7,
issue 5
页码: 275-281
ISSN:0114-2402
年代: 1994
出版商: ADIS
数据来源: ADIS
摘要:
1-Acetyl-4-phenyl-1,2,4-triazolidine-3,5-dione (APTD) has hypolipidaemic, anti-inflammatory, analgesic, antineoplastic, and aldose reductase inhibitory activities in animals. Disposition studies using pooled plasma and urine samples showed that [1-14C-acetyl]-1-acetyl-4-phenyl-1,2,4-triazolidine-3,5-dione (14C-APTD) had a maximum half-life of 20 hours. Urinary excretion accounted for less than 3% of the radioactivity elimination, while faecal excretion may account for up to 45% of the total elimination. In a 96-hour tissue distribution study, there was no sequestering of14C-APTD in any of the organs.14C-APTD demonstrated significant aqueous partitioning, and almost no binding to bovine serum albumin. In L1210tumour cells,14C-APTD was bound to DNA and RNA, and there was no binding to intracellular protein.14C-APTD underwent significant metabolism in mice. One metabolite excreted in urine was identified; two other possible metabolites were proposed.
点击下载:
PDF
(2945KB)
返 回
|
|